{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:08:14Z","timestamp":1790687294964,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.neuropharm.2020.108226","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T11:47:40Z","timestamp":1596714460000},"page":"108226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Contribution of mesolimbic dopamine and kappa opioid systems to the transition from acute to chronic pain"],"prefix":"10.1016","volume":"178","author":[{"given":"Fernanda","family":"Vergara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Fantin","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Pescador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele Oliveira","family":"Guaita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Aparecida","family":"Jark Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Geremias","family":"Chichorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108226_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pbb.2013.09.008","article-title":"Neural mechanisms of pain and alcohol dependence","volume":"112","author":"Apkarian","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108226_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuroscience.2010.08.040","article-title":"Peripheral nerve injury differentially regulates dopaminergic pathways in the nucleus accumbens of rats with either 'pain alone' or 'pain and disability","volume":"171","author":"Austin","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108226_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuroscience.2011.10.056","article-title":"Aversive stimulus differentially triggers subsecond dopamine release in reward regions","volume":"201","author":"Budygin","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108226_bib4","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.pain.2014.02.019","article-title":"Role of nucleus accumbens in neuropathic pain: linked multi-scale evidence in the rat transitioning to neuropathic pain","volume":"155","author":"Chang","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108226_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2010.04.052","article-title":"Age-dependent effects of kappa-opioid receptor stimulation on cocaine-induced stereotyped behaviors and dopamine overflow in the caudate-putamen: an in vivo microdialysis study","volume":"169","author":"Cortez","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108226_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nn.3628","article-title":"Pain vulnerability: a neurobiological perspective","volume":"17","author":"Denk","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108226_bib7","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1111\/ejn.13015","article-title":"Nucleus accumbens dopaminergic neurotransmission switches its modulatory action in chronification of inflammatory hyperalgesia","volume":"42","author":"Dias","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108226_bib8","doi-asserted-by":"crossref","first-page":"504691","DOI":"10.1155\/2015\/504691","article-title":"Neuroplasticity underlying the comorbidity of pain and depression","volume":"2015","author":"Doan","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2020.108226_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2015.11.027","article-title":"Common brain mechanisms of chronic pain and addiction","volume":"89","author":"Elman","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108226_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.06.003","article-title":"Pain and suicidality: insights from reward and addiction neuroscience","volume":"109","author":"Elman","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2020.108226_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0304-3959(90)91149-D","article-title":"Induction, blockade and restoration of a persistent hypersensitive state","volume":"42","author":"Ferreira","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108226_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jpain.2012.03.009","article-title":"The economic costs of pain in the United States","volume":"13","author":"Gaskin","year":"2012","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2020.108226_bib13","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1523\/JNEUROSCI.15-04-03154.1995","article-title":"Antinociception produced by an ascending spino-supraspinal pathway","volume":"15","author":"Gear","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108226_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11920-008-0051-0","article-title":"Comorbidity of pain and anxiety disorders","volume":"10","author":"Gureje","year":"2008","journal-title":"Curr. Psychiatr. Rep."},{"key":"10.1016\/j.neuropharm.2020.108226_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0014-2999(92)90055-9","article-title":"Long term kappa-opioid receptor blockade following nor-binaltorphimine","volume":"215","author":"Jones","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108226_bib16","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0022-3565(25)20805-9","article-title":"Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats","volume":"278","author":"Kelley","year":"1996","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108226_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2014.11.044","article-title":"The dark side of emotion: the addiction perspective","volume":"753","author":"Koob","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108226_bib18","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1523\/JNEUROSCI.0274-19.2019","article-title":"Kappa opioid receptors drive a tonic aversive component of chronic pain","volume":"39","author":"Liu","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108226_bib19","doi-asserted-by":"crossref","first-page":"9981","DOI":"10.1523\/JNEUROSCI.23-31-09981.2003","article-title":"Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons","volume":"23","author":"Margolis","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108226_bib20","doi-asserted-by":"crossref","first-page":"104504","DOI":"10.1016\/j.neuint.2019.104504","article-title":"Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion","volume":"129","author":"Margolis","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2020.108226_bib21","doi-asserted-by":"crossref","first-page":"9957","DOI":"10.1523\/JNEUROSCI.4605-14.2015","article-title":"Chronic back pain is associated with alterations in dopamine neurotransmission in the ventral striatum","volume":"35","author":"Martikainen","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108226_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuropharm.2013.04.007","article-title":"Noradrenaline increases pain facilitation from the brain during inflammatory pain","volume":"71","author":"Martins","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108226_bib23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neuron.2019.02.029","article-title":"Pain-induced negative affect is mediated via recruitment of the nucleus accumbens kappa opioid system","volume":"102","author":"Massaly","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108226_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12640-011-9278-3","article-title":"Behavioral, neurochemical and histological alterations promoted by bilateral intranigral rotenone administration: a new approach for an old neurotoxin","volume":"21","author":"Moreira","year":"2012","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2020.108226_bib25","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1471-4159.1987.tb00987.x","article-title":"Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra","volume":"49","author":"Nissbrandt","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108226_bib26","series-title":"Netter\u2019s essential histology","author":"Ovalle","year":"2013"},{"key":"10.1016\/j.neuropharm.2020.108226_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuroscience.2009.04.011","article-title":"Cognitive impairment of prefrontal-dependent decision-making in rats after the onset of chronic pain","volume":"161","author":"Pais-Vieira","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108226_bib28","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2020.108226_bib29","first-page":"409","article-title":"A method for measurement of analgesic activity on inflamed tissue","volume":"111","author":"Randall","year":"1957","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.neuropharm.2020.108226_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nn.4199","article-title":"The indirect pathway of the nucleus accumbens shell amplifies neuropathic pain","volume":"19","author":"Ren","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108226_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.1253994","article-title":"Chronic pain. Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens","volume":"345","author":"Schwartz","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108226_bib32","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1111\/ejn.13272","article-title":"Chronic pain disrupts the reward circuitry in multiple sclerosis","volume":"44","author":"Seixas","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108226_bib33","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/j.pain.0000000000000494","article-title":"Mesolimbic dopamine signaling in acute and chronic pain: implications for motivation, analgesia, and addiction","volume":"157","author":"Taylor","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108226_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2018.09.023","article-title":"Dynorphin\/kappa-opioid receptor control of dopamine dynamics: implications for negative affective states and psychiatric disorders","volume":"1713","author":"Tejeda","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108226_bib35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jpain.2008.05.005","article-title":"Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders","volume":"9","author":"Tsang","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2020.108226_bib36","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/brain\/aww100","article-title":"Corticolimbic anatomical characteristics predetermine risk for chronic pain","volume":"139","author":"Vachon-Presseau","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2020.108226_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918756406","article-title":"Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer","volume":"14","author":"Watanabe","year":"2018","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2020.108226_bib38","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1111\/j.1460-9568.2007.05623.x","article-title":"Fibromyalgia patients show an abnormal dopamine response to pain","volume":"25","author":"Wood","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108226_bib39","doi-asserted-by":"crossref","first-page":"116969","DOI":"10.1016\/j.neuroimage.2020.116969","article-title":"Impaired mesocorticolimbic connectivity underlies increased pain sensitivity in chronic low back pain","volume":"218","author":"Yu","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2020.108226_bib40","article-title":"The role of dopaminergic VTA neurons in general anesthesia","volume":"10","author":"Zhou","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2020.108226_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082030294X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082030294X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:04:15Z","timestamp":1758438255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082030294X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":41,"alternative-id":["S002839082030294X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108226","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of mesolimbic dopamine and kappa opioid systems to the transition from acute to chronic pain","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108226"}}